Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess for acute hemodynamic changes after implementation of noninvasive negative pressure ventilation (as compared with spontaneous respiration) in pediatric patients with Fontan failure using modern negative pressure ventilators
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hayek RTX ventilator | Experimental | Participants will receive noninvasive negative pressure ventilation. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hayek RTX ventilator | Device | Participants will receive Noninvasive negative pressure from the Hayek RTX ventilator for 30 minutes during diagnostic catheterization procedure. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Hemodynamics as characterized by change in pulmonary artery pressure | Pulmonary artery wedge pressure will be measured in millimeters of mercury (mmHg) at baseline and completion of noninvasive negative pressure ventilation. | Baseline, 45 Minutes |
| Hemodynamics as characterized by change in pulmonary blood flow | Change in pulmonary blood flow will be measured at baseline and completion of noninvasive negative pressure ventilation. | Baseline, 45 Minutes |
| Hemodynamics as characterized by change in systemic arterial saturation | Systemic arterial saturation measures the amount of oxygen in the blood stream. Systemic arterial saturation will be registered at baseline and completion of noninvasive negative pressure ventilation. | Baseline, 45 Minutes |
| Hemodynamics as characterized by change in cardiac output | Cardiac output will be measured in liters per minute at baseline and completion of noninvasive negative pressure ventilation | Baseline, 45 Minutes |
Not provided
Not provided
Inclusion Criteria:
1. Patients with Fontan physiology with clinical evidence of Fontan failure as defined by those with one of the following in addition to Fontan circulation: New York Heart Association Class II, fluid retention, cyanosis, protein losing enteropathy, renal/hepatic dysfunction and/or subjectively qualify for hemodynamic assessment (by primary cardiologist).
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Peng, MD | University of Michigan | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of MIchigan | Ann Arbor | Michigan | 48109 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided